Early Access to Medicines Scheme - bearing fruit?
A year on from the Early Access to Medicines Scheme (EAMS) and 4 medicines have received PIM designation and 1 full positive scientific opinion. This represents slow and steady progress for patient access to medicines. Will 2015 bear more fruit?
In the autumn of 2014 Empower: Access to Medicine convened a discussion, hosted by the President of the Royal Society of Medicine, examining the progress of EAMS and its current trajectory. The roundtable featured leading minds from the academic, pharmaceutical and campaigning world and featured robust discussion around the scope and ambition of the scheme.
This latest Empower: Access to Medicine report summarises key points from that discussion; and evaluates the progress of early access to date.
You can download the full report, here.